A. H. Chow-w, . Nyren-o, L. M. Berne-c, and . Ekbom-a, Excess risk of primary liver cancer in patients with Diabetes Mellitus, Journal of the National Cancer Institute, vol.20, pp.1472-1477, 1996.

A. C. Amrein-l, . Zakikhani-m, and . Panasci-l, Metformin blocks the stimulative effect of a high energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase, Endocrine- Related Cancer, vol.17, pp.351-360, 2010.

A. C. Amrein-l, D. S. Bazile-m, and . Zakikhani-m, Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo, Oncogene, vol.30, pp.1174-1182, 2011.

A. C. Zakikhani-m and S. J. Blouin-m, Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth, Endocrine-Related Cancer, vol.15, pp.833-839, 2008.

A. K. , A. E. Mink-p, H. C. Kushi-l, and . Sellers-t, Diabetes and endometrial cancer in the Iowa women's health study, Cancer Epidemiol Biomarkers Prev, vol.10, pp.611-616, 2001.

A. S. Wolk-a, . Bergström-r, . Giovannucci-e, . Lindgren-c, and . J. Baron, Energy, nutrient intake and prostate cancer risk: a population-based case-control study in Sweden, International Journal of Cancer, vol.68, pp.716-722, 1996.

A. V. Berstein-l, . Egormin-p, . Piskunova-t, . Popovich-i, and . Zabezhinski-m, Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice, Experimental Gerontology, vol.40, pp.685-693, 2005.

A. M. Pirgon-o, Use of metformin in obese adolescents with hyperinsulinemia: a 6-month, randomized, double-blind, placebo-controlled clinical trial, Journal of Pediatric Endocrinology and Metabolism, vol.21, pp.339-348, 2008.

A. E. Gridley-g, C. J. Leitzmann-m, and . Mcglynn-k, Risk of cancer in a large cohort of U.S. veterans with diabetes, International Journal of Cancer, vol.128, pp.635-643, 2011.

A. G. Rainey-w and . Carr-b, Metformin directly inhibits androgen production in human thecal cells, Fertility and Sterility, vol.76, pp.517-524, 2001.

A. G. Mansuy-v, . Voirol-m, and . Pellerin-l, The anorexigenic effects of metformin involve increases in hypothalamic leptin receptor expression, Metabolism, vol.60, pp.327-334, 2011.

A. M. Lyons-t, Diabetes, insulin treatment, and cancer risk : What is the evidence? Medecine Reports, pp.1-4, 2010.

B. C. Mittleman-m, . Kawachi-i, . Giovannucci-e, and . Glasser-d, A prospective study of risk factors for erectile dysfunction, Journal of Urology, vol.176, pp.217-221, 2006.

B. A. Elnashar-a, Treatment options for polycystic ovary syndrome, International Journal Of Women " s Health, pp.25-35, 2011.

B. Swanson-c, Body weight : estimation of risk for breast and endometrial cancers, American Journal of Clinical Nutrition, vol.63, pp.437-441, 1996.

B. S. Dossus-l, Obesity related hyperinsulinaemia and hyperglycaemia and cancer development, Archives of Physiology and Biochemistry, vol.115, pp.86-96, 2009.

B. Sahra, I. , L. K. Giuliano-s, . Larbret-f, . Ponzio-g et al., Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells, Cancer Reseach, vol.70, pp.2665-2675, 2010.

B. Sahra, I. , L. K. , L. A. Giorgetti-peraldi, C. P. et al., The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level, Oncogene, vol.14, issue.25, pp.3576-3586, 2008.
DOI : 10.1172/JCI200113505

URL : https://hal.archives-ouvertes.fr/inserm-00277135

B. Sahra, I. , L. Y. Marchand-brustel, and T. J. Bost-f, Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?, Molecular Cancer Therapeutics, vol.9, issue.5, pp.1092-1099, 2010.
DOI : 10.1158/1535-7163.MCT-09-1186

B. M. , M. C. , K. S. , and J. S. Meier-c, Long-term metformin use is associated with decreased risk of breast cancer, Diabetes Care, vol.33, pp.1304-1308, 2010.

B. B. Orendas-p, . Garajova-m, . Kassayova-m, and A. E. Kutna-v, Metformin in chemically-induced mammary carcinogenesis in rats, Neoplasma, vol.56, pp.269-274, 2009.

B. J. , A. S. Serensen-h, . Pederson-l, and . Lash-t, Metformin and incident breast cancer among diabetic women : a population-based casecontrol study in Denmark, Cancer Epidemiologic Biomarkers Prevention, vol.20, pp.101-111, 2010.

B. M. Uzzan-b and . Cohen-r, Metformin and digestive disorders, Diabetes and Metabolism, vol.37, pp.90-96, 2011.

B. R. Supper-i, . T. Bejan-angoulvant, C. M. Kellou-n, and . J. Boissel, Reappraisal of Metformin efficacy in the treatment of type 2 Diabetes : A meta-analysis of randomised of controlled trials Plos Medecine, 2012.

B. S. Majumdar-s and J. J. Veugelers-p, Increased cancerrelated mortality for patients with type 2 diabetes who use sulfonylureas or insulin, Diabetes Care, vol.29, pp.254-258, 2006.

B. M. Jones-r, A. R. Lum-j, . Deberardinis-r, and . Zhao-f, Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth, Cancer Research, vol.67, pp.6745-6752, 2007.

C. L. Zhou-c, M. A. Malloy-k, and G. P. Bae-jump-v, Metformin is a potent inhibitor of endometrial cancer cell proliferationimplications for novel strategy, Gynecologic Oncology, vol.116, pp.92-98, 2010.

C. J. Bernstein-l, D. S. Severson-r, C. J. , and B. A. , Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma, Cancer Causes and Control, vol.16, pp.1203-1214, 2005.

C. K. Huszar-j, . Best-a, and E. P. Sharma-s, Longterm effect of Metformin on metabolic parameters in the polycystic ovary syndrome. Diabetes and Vascular Disease Research, pp.110-119, 2009.

C. Y. Zhou-k, W. R. Liu-y, and M. T. Kwak-y, Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription, Proceedings of the National Academy of Sciences, vol.106, pp.3907-3912, 2009.

C. B. Duncan-l, Comparison of chlorpropamide and metformin treatment on weight and blood-glucose response of uncontrolled obese diabetics, Lancet, pp.123-126, 1968.

C. M. Chapman-m and . Conway-u, A systematic review and metaanalysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome, Human Reproduction, pp.1387-1399, 2006.

C. S. , C. E. Teras-l, and P. J. Thun-m, Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults, American Journal of Epidiology, vol.159, pp.1160-1167, 2004.

C. A. and B. H. Mccormick-c, Use of metformin in polycystic ovary syndrome: a meta-analysis, Obstetrics & Gynecology, pp.959-968, 2008.

C. C. Poole-c and . Gale-e, The influence of glucose-lowering therapies on cancer risk in type 2 diabetes, Diabetologia, vol.52, pp.1766-1777, 2009.

D. J. , M. R. Shaib-y, K. Mcglynn, and E. Et, Diabetes increases the risk of hepatocellular carcinoma in the United States : a population based case control study, Gut, vol.54, pp.533-539, 2005.

D. Jager, J. , K. A. Lehert-p, . Wulffele-m, . J. Van-der-kolk et al., Traitement par metformine et déficit en vitamine B12. Médecine des maladies métaboliques, pp.51-52, 2011.

D. and C. C. Kandaraki-e, Metformin : an old medication of new fashion : evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome, European Journal of Endocrinology, vol.162, pp.193-212, 2010.

D. W. Balbi-m, C. P. Vario-a, and A. A. Et, Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy : Potentiale role of insuline, World Journal of Gastroenterology, vol.14, pp.5695-5700, 2008.

D. L. Zhou-q, . Zhang-z, . Zhu-y, and . Duan-t, Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression, Journal of Obstetrics and Gynaecology Research, 2012.

D. R. Goodwin-p and . Stambolic-v, Understanding the benefit of Metformin use in cancer treatment, BMC Medecine, vol.33, pp.1-6, 2011.

D. A. Pawelczyk-l, . Yuen-b, and . Moon-y, Insulin actions on ovarian steroidogenesis are not modulated by metformin, Human Reproduction, vol.8, pp.1194-1198, 1993.

D. J. Roberts-d, . Furlong-t, . Kumar-s, . Greenfield-j, and . Kirkpatrick-c, Metformin therapy in patients with chronic kidney disease. Diabetes Obesity and Metabolism, 2012.

E. A. and T. S. Bjørge-t, Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men, British Journal of Cancer, vol.89, pp.1237-1242, 2003.

E. K. Giugliano-f, . Di-palo-c, . Giugliano-g, D. Marfella-r, and A. F. , Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial, Journal of the American Medical Association, vol.291, pp.2978-2984, 2004.

E. J. , D. A. , A. M. Ogston-s, and M. A. Petrie-j, Effect of Metformin on mortality in patients with heart failure and type 2 diabetes mellitus, American Journal of Cardiology, vol.106, pp.1006-1010, 2010.

E. J. Donnelly-l, A. A. Emslie-smith, and . Morris-a, Metformin and reduced risk of cancer in diabetic patients, British Medical Journal, vol.330, pp.1304-1305, 2005.

E. J. Ogston-s, . A. Emslie-smith, and . Morris-a, Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin, Diabetologia, vol.49, pp.930-936, 2006.

E. J. Et and W. , Diabetes mellitus as a risk factor for pancreatic cancer, Journal of the American Medical Association. Mai, pp.1605-1609, 1995.

F. A. Strayer-l, S. C. Et, and S. A. , Diabetes and risk of incident colorectal cancer in a prospective cohort of women, Cancer Causes Control, vol.21, pp.1277-1284, 2010.

F. M. , H. S. Leclerc-j, Z. E. Soty-m, and . Mithieux-g, Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state, Journal of clinical Investigation, vol.120, pp.2355-2369, 2010.

F. M. Bursey-d, The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes, Pediatrics, vol.107, p.55, 2001.

F. E. Mantzoros-c and W. Et, Diabetes and risk of endometrial cancer : a population-based prospective cohort study, Cancer Epidemiol Biomarkers Prev, vol.16, pp.276-280, 2007.

G. S. Gann-p, . Lowe-w, . Liu-k, . Colangelo-l, and D. A. Et, Abnormal glucose metabolism and pancreatic cancer mortality, JAMA. Mai, pp.2552-2558, 2000.

G. E. , H. D. Archer-m, and . Bergenstal-r, Diabetes and cancer : a consensus report, Diabetes Care, vol.33, pp.1674-1685, 2010.

G. E. , R. E. Stampfer-m, and C. G. , Diabetes mellitus and risk of prostate cancer, Cancer Causes Control, vol.9, pp.3-9, 1998.

G. C. , W. P. Goldenberg-n, and . Sieve-smith-l, Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin, Human Reproduction, vol.17, pp.2858-2864, 2002.

G. J. Sadler-l, Metformin for gestational diabetes in routine clinical pratice, Diabet Med, vol.28, pp.1082-1087, 2011.

G. Z. Neuhouser-m, A. D. Goodman-p, and C. C. Hsing-a, Obesity, diabetes, and risk of prostate cancer : results from the prostate cancer prevention trial, Cancer Epidemiology Prev, vol.15, pp.1977-1983, 2006.

G. Meric-bernstam-f, Metformine : a therapeutic opportunity in breast cancer, Clinical Cancer Research, vol.16, pp.1695-1700, 2010.

G. M. , H. J. Wilkens-l, . Lyu-l, . Mcduffie-k, and . Liu-l, Diet, body size, physical activity, and the risk of endometrial cancer, Cancer Research, vol.57, pp.5077-5085, 1997.

G. A. , C. N. Maciel-t, L. M. Willems-l, and A. C. , The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation, Blood Journal, vol.18, pp.4262-4273, 2010.

G. F. , A. F. Filipponi-p, and M. S. Testa-i, Is metformin safe enough for ageing type 2 diabetic patients? Diabetes & Metabolism, pp.43-50, 1996.

G. T. Goldberg-a and . Shavit-l, Metformin as an addition to conventional chemotherapy in breast cancer, Journal of Clinical Oncology, vol.27, 2009.

G. L. Pezzilli-r and . Morselli-labate-a, Diabetes and risk of pancreatic Cancer. The New Ingland of, Journal, vol.331, pp.81-84, 1994.

G. S. , C. J. , J. S. Toedt-pingel, and J. S. Nunez-d, Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure, Circulation Research, pp.403-411, 2008.

H. R. Zhou-c, S. L. Malloy-k, . Zhong-y, and . Gehrig-p, Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway, Gynecologic Oncology, vol.125, pp.458-469, 2012.

H. L. Sattar-n and N. J. Fleming-r, Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses, Journal of Clinical Endocrinology and Metabolism, vol.90, pp.4593-4598, 2005.

H. M. Curley-s, L. D. , K. A. Davila-m, and A. E. , Association of Diabetes Treatement with the risk of Hepatocellular Carcinoma, pp.1938-1946, 2010.

H. K. , L. X. , and S. J. Sundquist-k, Risk of cancer following hospitalization for type 2 diabetes. The Oncologist, pp.548-555, 2010.

H. H. , I. D. Tsichlis-p, and . Struhl-k, Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission, Cancer Research, vol.69, pp.7507-7511, 2009.

H. K. Endo-h, . Takahashi-h, . Sugiyama-m, . Uchiyama-t, and . Suzuki-k, Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase, Molecular Carcinogenesis, vol.49, pp.662-671, 2010.

H. X. , W. S. Shpiro-n, . Mcguire-v, . Sakamoto-k, and . Woods-y, Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice, Biochemical Journal, vol.412, pp.211-221, 2008.

H. R. Ansary-moghaddam, . Berrington-de-gonzalez-a, . Barzi-f, and W. Et, Type-2 diabetes and pancreatic cancer : a metaanalysis of 36 studies, British Journal of Cancer, vol.92, pp.2076-2083, 2005.

I. H. Vääräsmäki-m, . L. Morin-papunen, . Keravuo-r, . Ebeling-t, and . Saarela-t, Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study, An International Journal of Obstetrics & Gynaecology, vol.118, pp.880-885, 2011.

I. P. Bodmer-m and J. S. Meier-c, Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study, Journal of the American Geriatrics Society, vol.60, pp.916-921, 2012.

I. M. Iwasaki-m, . Otani-t, . Sasazuki-s, and . Noda-m, Diabetes mellitus and the risk of cancer: results from a large-scale populationbased cohort study in Japan, Archives of Internal Medecine, vol.166, pp.1871-1877, 2006.

J. M. , G. J. , L. J. De, J. S. , and R. A. Gans-r, Metformin : taking away the candy for cancer ?, European Journal of Cancer, vol.46, pp.2369-2380, 2010.

J. S. Ohrr-h, S. J. , Y. J. , J. M. Et, and S. J. , Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women, JAMA, vol.293, pp.194-202, 2005.

J. S. , P. S. , G. S. Meric-bernstam, and B. C. Liedtke-c, Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer, American Society of Clinical Oncology, vol.27, pp.3297-3302, 2009.

J. F. Wolk-a, . Pedersen-n, T. P. Lichtenstein-p, and A. A. , Obesity and hormone-dependent tumors : cohort and co-twin control studies based on the Swedish Twin Registry, International Journal of Cancer, vol.106, pp.594-599, 2003.

J. E. Lombard-h, . Burrows-r, and . Manning-m, Diabetes and cancer, New England of Journal, vol.260, pp.486-488, 1959.

K. S. , H. S. Heise-m, H. W. Holman-r, and . Jones-n, Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy, The New England Journal of Medicine, vol.355, pp.2427-2443, 2006.

K. J. Et and G. E. , A meta-analysis of diabetes mellitus and the risk of prostate cancer, Cancer Epidemiology Biomarkers Prevention, vol.15, pp.2056-2062, 2006.

K. J. Liu-y and G. E. Et, Diabetes Mellitus and risk of prostate cancer in the health professionals follow-up study, National Institutes of Health. Mars, vol.124, pp.1398-1403, 2009.

K. M. Mori-m, . Fujino-y, . Shibata-a, . Sakauchi-f, and . Washio-m, Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study, Asian Pacific Journal of Cancer Prevention, vol.7, pp.253-259, 2006.

K. E. Bagis-t, . Tarim-e, E. S. Aslan-e, and . Simsek-e, Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial, Human Reproduction, vol.20, pp.1521-1528, 2005.

K. Y. , P. S. , K. J. , H. J. , and J. W. Yoon-c, Metformin restores the penile expression of nitric oxide synthase in high-fat-fed obese rats, Journal of Andrology, vol.28, pp.555-556, 2007.

K. K. and E. G. Sinnett-smith, Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth, Cancer Research, vol.69, pp.6539-6545, 2009.

K. E. Tziomalos-k, D. K. , K. I. Kalaitzakis-e, and D. D. , The effect of weight loss and treatment with Metformin on serum vaspin levels in women with polycystic ovary syndrome, Endocrine Journal Advance Publication, vol.10, pp.1-10, 2010.

K. E. Liszek-m, . Emanuele-m, . R. Durazo-arvizu, and . Camacho-p, Effect of metformin therapy on vitamin D and vitamin B12 levels in patients with type 2 diabetes mellitus, Endocrine Pratice, vol.18, pp.179-184, 2011.

K. A. and A. E. Mink-p, Diabetes and Endometrical Cancer in the lowa Women's Health Study, Cancer Epidemiol Biomarkers Prev, vol.10, pp.611-616, 2001.

L. Vecchia, C. Negri-e, F. S. D-"-avanzo, and . Boyle-p, A case-control study of diabetes mellitus and cancer risk, British Journal of Cancer, vol.70, issue.5, pp.950-953, 1994.
DOI : 10.1038/bjc.1994.427

L. S. Orsini-n and W. Et, Diabetes Mellitus and Risk of Colorectal Cancer : A Meta-Analysis, Journal of National Cancer Institute, vol.97, pp.1679-1687, 2005.

L. S. Wolk-a, Diabetes mellitus and incidence of kidney cancer : a meta-analysis of cohort studies, Diabetologia, vol.54, pp.1013-1018, 2009.

L. A. Strong-j, R. P. Peattie-p, and . Gibson-a, Comparison of fenfluramine and metformin in treatment of obesity, Lancet, vol.2, pp.437-441, 1970.

L. M. Hsu-c, . Wahlqvist-m, C. Y. Tsai-h, and H. Et, Types 2 Diabetes increases and Metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese : a representative population cohort study of 800 000 individuals, Biomed Central Cancer, pp.11-20, 2010.

L. R. Barnhart-h, . Schlaff-w, D. M. Carr-b, and C. S. , Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome, New England Journal of Medecine, vol.356, pp.551-566, 2007.

L. K. Slaymaker-e, Y. J. Last-a, and . Ference-j, Metformin as treatment for overweight and obese adults: a systematic review, The Annals of Family Medicine, vol.3, pp.457-461, 2005.

L. C. , D. J. Tang-m, and . Malone-k, Relationship between diabetes and risk of second primary contralateral breast cancer, Breast Cancer Research and Treatment, vol.125, pp.541-545, 2010.

L. G. Donnelly, L. Donnan-p, A. D. , and M. A. Evans, New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes, Diabetes Care, vol.32, pp.1620-1625, 2009.

L. P. Chow-w, C. J. Bergström-a, and . Wolk-a, The role of diabetes mellitus in the aetiology of renal cell cancer, Diabetologia, vol.42, pp.107-112, 1999.

L. K. Vatten-l, . M. Ellstrom-engh, and E. A. Et, Body mass, diabetes and smoking, and endometrial cancer risk : a follow-up study, British Journal of Cancer, vol.98, pp.1582-1585, 2008.

L. B. , F. Z. Edgerton-s, A. I. Deng-x, and L. S. , Metformin induces unique biological and molecular responses in triple negative breast cancer cells, Cell Cycle, vol.8, pp.2031-2040, 2009.

L. J. Flight-i and . Norman-r, Metformin in polycystic ovary syndrome: systematic review and meta-analysis, British Medical Journal, vol.327, pp.951-953, 2003.

M. F. , I. S. , W. Y. Havranek-e, and F. J. , Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study, Circulation, vol.111, pp.583-590, 2005.

M. R. , A. C. , and Y. J. Trivax-b, Use of Metformin in polycystic ovary syndrome, American Journal of Obstetrics and Gynecology. Décembre, vol.199, pp.596-609, 2008.

M. Y. Hirasawa-y, . Sugiura-t, . Toyoshi-t, . Kyuki-k, and . Ito-m, Metformin reduces body weight gain and improves glucose intolerance in high-fat diet-fed C57BL/6J mice, Biological and Pharmaceutical Bulletin, vol.33, pp.963-970, 2010.

M. L. Malmberg-k, N. A. , and W. H. , Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study, Diabetologia, vol.54, pp.1308-1317, 2011.

M. R. Mercado-j, K. S. Maier-c, and F. S. Dennis-p, Metformin prevents tobacco carcinogen--induced lung tumorigenesis, Cancer Prevention Research, vol.3, pp.1066-1076, 2010.

M. R. Green-l, G. J. Stadel-b, and G. A. Fleming-g, Lactic acidosis in patients with diabetes treated with metformin, New England Journal of Medecine, vol.338, pp.265-266, 1998.

M. J. Castillo-j and P. A. Et, Diabetes and risk of non-hogkin's lymphoma, Diabetes Care, vol.31, pp.2391-2397, 2008.

M. E. Van-der, . F. Veen, and . Van, The role of metformin in polycystic ovary syndrome: a systematic review, Human Reproduction Update, pp.527-537, 2007.

M. M. , C. C. Balzi-d, G. S. Dicembrini-i, and M. C. , Metformin and cancer occurrence in insulin-treated type2 diabetic patients. Diabetes journals, 2010.

M. M. and G. J. Schlieman-m, AKT: A novel target in pancreatic cancer therapy. Cancer therapy, pp.227-238, 2004.

M. J. , M. A. , M. A. , and W. E. Duncan-l, Weight-reducing effect of diguanides in obese non-diabetic women, British medical journal, vol.2, pp.13-15, 1969.

N. M. , L. A. , R. F. Faulhaber-g, . Leite-c, and . Fischer-l, Vitamin B12 in metformin-treated diabetic patients: a crosssectional study in Brazil, Revista da Associação Médica Brasileira, vol.57, pp.46-49, 2011.

N. K. Sweeney-c and . Folsom-a, Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women, International Journal of Cancer, vol.108, pp.115-121, 2004.

O. A. Ogston-s and M. A. Evans, A cohort study of the risk of cancer associated with type 2 diabetes, British Journal of Cancer, vol.101, pp.1199-1201, 2009.

P. S. Falbo-a, . Giallauria-f, . Russo-t, . Tolino-a, and . Zullo-f, Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome, Diabetes Care, pp.246-251, 2010.

P. S. Falbo-a, . Zullo-f, and . Orio-f, Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review, Endocrine Reviews, vol.30, pp.1-50, 2009.

P. R. , G. A. Biscotti-d, . Vicennati-v, and C. D. Gagliardi-l, Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome, The Journal of Clinical Endocrinology & Metabolism, vol.85, pp.2767-2774, 2000.

P. E. , W. M. , C. P. Harms-g, and W. L. Shen-h, Enhancing CD8 T-cell memory by modulating fatty acid metabolism, Nature, vol.460, pp.103-107, 2009.

P. M. Oh-r, . Saguil-a, and S. D. Seehusen-d, The prevalence of vitamin B(12) deficiency in patients with type 2 diabetes: a cross-sectional study, Journal Of American Board of the Familiy medecine, vol.22, pp.528-534, 2009.

R. A. Kuhadiya-n and R. K. Fonseca-v, Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality?: a meta-analysis of observational studies, Diabetes Care, vol.31, pp.1672-1678, 2008.

R. K. , S. J. , K. J. Ulmer-h, and C. H. Diem-g, Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria, Diabetologia, vol.54, pp.945-952, 2006.

R. R. , G. S. Hartmann-l, and . Shridhar-v, Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner, Journal of Cellular and Molecular Medicine, pp.166-178, 2011.

R. L. Qi-y, G. J. Williamson-r, and . Oaklay-g, Association of biochemical B12 deficiency with Metformin therapy and vitamin B12 supplements, Diabetes Care, vol.35, pp.327-333, 2011.

R. C. , P. A. , M. A. Jacobs-e, . Thun-m, and C. E. Et, Diabetes and risk of prostate cancer in a prospective cohort of US men, American Journal of Epidemiology, vol.161, pp.147-152, 2005.

R. R. Travert-f, W. P. Pasquet-b, and S. S. Goto-s, Metformin use and mortality among patients with diabetes and atherothrombosis, Archive Internal of Medecine, vol.170, pp.1892-1899, 2010.

R. J. , H. W. Gao-w, M. M. Battin-m, . Mig, and . Investigators, Metformin versus insulin for the treatment of gestational diabetes, New England Journal of Medecine, pp.2003-2015, 2008.

S. S. Greyber-e, . Pasternak-g, and . Salpeter-e, Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus, Cochrane Data Base of Systematic Review, 2010.

S. S. Greyber-e, . Pasternak-g, and . Salpeter-e, Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis, Archive Internal of Medecine, vol.163, pp.2594-2602, 2003.

S. B. Doherty-j, H. D. Beresford-s, and C. C. Voigt-l, Diabetes and Endometrial cancer : an evaluation of the modifying effects of other known risk factors, American Journal of Epidemiology, vol.167, pp.607-614, 2008.

S. M. , M. H. , H. J. , U. A. , and S. J. Ding-x, Prevention of pancreatic cancer induction in hamsters by metformin, Gastroenterology, vol.120, pp.1263-1270, 2001.

S. L. Goldbohm-r, . Van-den, and . Brandt-p, Anthropometry, physical activity, and endometrial cancer risk : results from the Netherlands cohort study, International Journal of Gynecological Cancer, vol.16, p.492, 2006.

S. E. Bolen-s, Y. H. , W. C. , W. L. , and M. S. , Cardiovascular outcomes in trials of oral diabetes medications: a systematic review, Archive internal of Medecine, vol.168, pp.2070-2080, 2008.

S. S. Bierhaus-a, . Schuetz-f, . Beckhove-p, . Schneeweiss-a, and . Sohn-c, Therapeutic effects of Metformin in breast cancer : involvement of the immune system? Cancer Immunology Immunother, pp.1221-1225, 2011.

S. J. , T. S. Garzotto-m, . Beer-t, . Derenick-r, and . Palma-a, Statins and prostate cancer risk: a case-control study, American Journal of Epidemiology, vol.162, pp.318-325, 2005.

S. R. Lamia-k, K. S. Vasquez-d, . Bardeesy-n, and . Depinho-r, The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin, Science, vol.310, pp.1642-1646, 2005.

S. S. , P. A. Et, and N. , Diabetes, body size and risk of endometrial cancer, American Journal of epidemiology, vol.148, pp.234-240, 1998.

S. D. Schiffman-m, . Everhart-j, . Goldstein-a, and . Lillemoe-k, Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer, British Journal of Cancer, vol.80, pp.1830-1837, 1999.

S. D. Balkau-b, Diabetes mellitus, hyperglycaemia and cancer, Diabetes and Metabolism, vol.36, pp.182-197, 2010.

S. B. Götte-m, . Wülfing-p, . Schüring-a, and . Kiesel-l, Metformin alters insulin signaling and viability of human granulosa cells, Fertility and Sterility, vol.84, pp.1173-1179, 2005.

S. S. Ambler-g, G. S. Baur-l, and Y. F. Tepsa-m, Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin, The Journal of Clinical Endocrinology and Metabolism, vol.91, pp.2074-2080, 2006.

S. P. Björ-o, L. A. Ferrari-p, . Lenner-p, and . Lindahl-b, Prospective study of hyperglycemia and cancer risk, Diabetes Care, vol.30, pp.561-567, 2007.

S. X. Foretz-m, . Taleux-n, . Van-der-zon-gc, and H. L. Sokal-e, Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status, Diabetologia, vol.54, pp.3101-3110, 2011.

S. C. Potischman-n, . Wilbanks-g, . Twiggs-l, . Mortel-r, and . Berman-m, Relation of endometrial cancer risk to past and contemporary body size and body fat distribution, Cancer Epidemiology Biomarkers and Prevention, vol.2, pp.321-327, 1993.

S. A. Laing-s, . Qiao-z, . Slater-s, . Burden-a, and . J. Botha, Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study, British Journal of Cancer, vol.92, pp.2070-2075, 2005.

T. A. Varughese-g, . J. Scarpello, and . Hanna-f, Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated?, British Medical Journal, vol.335, pp.508-512, 2007.

T. T. Lord-j-m, N. R. , and Y. E. Balen-a, Insulin-sensitising drugs (Metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo-amenorrhoea and subfertility, Cochrane Database System Revue, vol.20, p.3053, 2010.

T. L. Kalnina-i, . Geldnere-k, R. R. Bumbure-a, and . L. Nikitina-zake, Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformintreated type 2 diabetes patients, Pharmacogenetics and Genomics, 2012.

T. R. Szeto-c, C. M. , and M. K. Chow-k, Risk factors of vitamin B(12) deficiency in patients receiving metformin, Archives of Internal Medicine, pp.1975-1979, 2006.

T. A. Endo-h, . Sugiyama-m, . Fujisawa-t, . Hosono-k, and . Takahashi-h, Metformin suppresses intestinal polyp growth in ApcMin/+ mice. Cancer science, pp.2136-2141, 2008.

T. L. , R. C. , C. C. , and T. S. Dupont, Metformin decreases IGF1-induced cell proliferation and protein synthesis through AMP-activated protein kinase in cultured bovine granulosa cells, Reproduction, vol.139, pp.409-418, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01129436

T. R. Potischman-n, . Hoover-r, and . Sliteri-p, Insulin and endometrial cancer, American Journal of Epidemiology, vol.146, pp.476-482, 1997.

T. K. Jang-h, K. Y. Nizamutdinova-i, and L. Y. Kim-h, Metformin inhibits HMGB1 release in LPS-treated RAW 264,7 cells and increases survival rate of endotoxaemic mice, British Journal of Pharmacology, vol.162, pp.1498-1508, 2011.

V. G. Costanzo-p, L. A. Finger-l, . Gueglio-g, and . Litwak-l, Addition of metformin to sildenafil treatment for erectile dysfunction in eugonadal non-diabetic men with insulin resistance. A prospective, randomized, double blind pilot study, Journal of Andrology, pp.1-2, 2011.

V. Berlo-van-de-laar-i and . Vermeij-c, Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements, Journal of Clinical Pharmacy and Therapeutics, vol.5, issue.3, pp.376-382, 2011.
DOI : 10.1046/j.1463-1326.2003.00241.x

V. Santbrink, E. Hohmann-f, and L. J. Eijkemans-m, Does metformin modify ovarian responsiveness during exogenous FSH ovulation induction in normogonadotrophic anovulation? A placebo-controlled double-blind assessment, European Journal of Endocrinology, vol.8, issue.11, pp.611-617, 2005.
DOI : 10.1210/jc.85.2.676

V. D. , R. V. Evans-w, and K. S. Stovall-d, Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone, Fertility and Sterility, vol.75, pp.310-315, 2001.

V. P. Frasca-f, . Sciacca-l, . Pandini-g, and V. R. Et, Diabetes and cancer. Endocrinology Relation Cancer, Décembre, vol.16, pp.1103-1123, 2009.

V. B. Foretz-m, . Leclerc-j, . Hardieg, and S. K. Et, Quels outils pharmacologiques utiliser pour activer l'AMPK ? AICAR, metformine ou A769662, un nouvel activateur de l'AMPK, Diabetes and Metabolism, vol.34, p.23, 2008.

W. F. Herrington-m, L. J. Et, and P. J. , The relationship between diabetes and pancreatic cancer, Mol Cancer, vol.2, pp.1-5, 2003.

W. M. Mori-m, . Khan-m, . Sakauchi-f, . Watanabe-y, and . Ozasa-k, Diabetes mellitus and kidney cancer risk: the results of Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study), International Journal of Urology, vol.14, pp.393-397, 2007.

W. M. Mori-m, . Sakauchi-f, . Watanabe-y, . Ozasa-k, and . Hayashi-k, Risk factors for kidney cancer in a Japanese population: findings from the JACC Study, Journal of Epidemiology, vol.15, pp.203-211, 2005.

W. K. , H. B. , S. D. , W. P. Kolonel-l, and H. C. Et, Association of diabetes with prostate cancer risk in the multiethnic cohort, American Journal of Epidemiology, vol.169, pp.937-945, 2008.

W. L. Gridley-g, . Chow-w, and L. M. Et, Cancer Incidence in a population-based Cohort of Patients Hospitalized with Diabetes Mellitus in Denmark, Journal of the National Cancer Institute, vol.89, pp.1360-1365, 1997.

W. J. Joshi-s, . Viollet-b, and . Hay-n, AMPK as a therapeutic target in renal cell carcinoma, Cancer Biology & Therapy, vol.10, pp.1168-1177, 2010.

W. P. Wierusz-wysocka-b, Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin, Expert Review of Molecular Diagnostics, vol.10, pp.509-519, 2010.

W. J. Et and S. J. , Metformin use and prostate cancer in Caucasian men : results from a population-based case-control study, Cancer Causes Control, vol.20, pp.1617-1622, 2009.

Y. J. , K. J. Salaita-c, . Mcduffie-j, . Kozlosky-m, and . Sebring-n, Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial, Diabetes, vol.60, pp.477-485, 2011.

Y. J. Schaison-g, Médecine thérapeutique, pp.659-72, 1997.

Y. J. Kang-k and . Yoo-m, Erectile potentials of a new phosphodiesterase type 5 inhibitor, DA-8159, in diet-induced obese, Asian Journal of Andrology, vol.8, pp.325-329, 2006.

Z. M. Dowling-r, . Fantus-i, and . Sonenberg-n, Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells, Cancer Research, vol.66, pp.10269-10273, 2006.

Z. K. Nyrén-o, A. H. Ostenson-c, E. A. Et, and Y. W. , Cancer incidence in patients with type 1 Diabetes Mellitus : a population-based cohort study in Sweden, Journal of the National Cancer Institute, vol.95, pp.1797-1800, 2003.

Z. G. Myers-r, L. Y. , C. Y. Shen-x, and . J. Fenyk-melody, Role of AMP-activated protein kinase in mechanism of metformin action, Journal of Clinical Investigation, vol.108, pp.1167-1174, 2001.